Skip to content

Study · Non-randomized trial · n = 43 · 2017

4 results

[The efficacy of cerebrolysin in the treatment of autism spectrum disorders].

Chutko LS, Yakovenko EA, Surushkina SY, Kryukova EM, Palaieva SV

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2017Cited by 1 (Europe PMC)

PMID29053124 (opens in a new tab)DOI10.17116/jnevro20171179171-75 (opens in a new tab)PepBankPUB-29053124
Publisher pagePubMedAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

4 results from studies that gave the peptide. 4 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In children with autism spectrum disorders, 27 children (62.8%) showed signs of improvement after Cerebrolysin treatment.

    In plain wordsIn children with autism spectrum disorders, 62.8% showed improvement after Cerebrolysin treatment compared with their previous condition.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseSigns of improvement
    Study

    n = 43

    Outcome group
    Autism core symptoms · Nervous system and cognition
    Studied dose
    Dose not stated

    Measurements

    Children with improvement
    27 children
    all children
    Improvement proportion
    62.8%
    all children

    Source sentences

    Summary
    After treatment with cerebrolysin, 27 children (62.8%) showed signs of improvement.
    1 context sentence
    Summary · context
    Forty-three children with autism spectrum disorders, aged 4-6 years, were included in the study.
  2. 02HumanNon-randomized trialEfficacy outcome

    In children treated with Cerebrolysin, CARS scores decreased more in organic autism than in endogenous autism.

    In plain wordsIn children treated with Cerebrolysin, autism severity scores decreased more in organic autism than in endogenous autism.

    Peptide
    Cerebrolysin
    Outcome
    DecreaseCARS score decrease by autism subgroup
    Study

    n = 43

    Comparator
    Children with endogenous autism
    Outcome group
    Autism core symptoms · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    CARS scores showed a more pronounced decrease in this indicator in a subgroup of children with organic autism.
    1 context sentence
    Summary · context
    Forty-three children with autism spectrum disorders, aged 4-6 years, were included in the study.
  3. 03HumanNon-randomized trialEfficacy outcome

    After Cerebrolysin treatment, 13 children with endogenous autism (56.5%) showed improvement.

    In plain wordsIn children with endogenous autism, 56.5% showed improvement after Cerebrolysin treatment compared with their previous condition.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseImprovement in endogenous autism subgroup
    Study

    n: not reported in source

    Outcome group
    Autism core symptoms · Nervous system and cognition
    Studied dose
    Dose not stated

    Measurements

    Children with improvement
    13 children
    endogenous autism
    Improvement proportion
    56.5%
    endogenous autism

    Source sentences

    Summary
    An improvement was noted in 13 children in with endogenous autism (56.5%) and in 14 children with organic autism (70.0%).
    1 context sentence
    Summary · context
    Forty-three children with autism spectrum disorders, aged 4-6 years, were included in the study.
  4. 04HumanNon-randomized trialEfficacy outcome

    After Cerebrolysin treatment, 14 children with organic autism (70.0%) showed improvement.

    In plain wordsIn children with organic autism, 70.0% showed improvement after Cerebrolysin treatment compared with their previous condition.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseImprovement in organic autism subgroup
    Study

    n: not reported in source

    Outcome group
    Autism core symptoms · Nervous system and cognition
    Studied dose
    Dose not stated

    Measurements

    Children with improvement
    14 children
    organic autism
    Improvement proportion
    70%
    organic autism

    Source sentences

    Summary
    An improvement was noted in 13 children in with endogenous autism (56.5%) and in 14 children with organic autism (70.0%).
    1 context sentence
    Summary · context
    Forty-three children with autism spectrum disorders, aged 4-6 years, were included in the study.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.